Holen Sie sich die Stockscreener-App
291.86
6.38%
-19.89
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$311.75
Offen:
$287.97
24-Stunden-Volumen:
6.44M
Relative Volume:
2.19
Marktkapitalisierung:
$111.95B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
33.81
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
-4.98%
1M Leistung:
+5.98%
6M Leistung:
-7.38%
1J Leistung:
-20.90%
1-Tages-Spanne:
$282.18
$299.17
1-Wochen-Bereich:
$282.18
$312.80
52-Wochen-Spanne:
$267.00
$389.33
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
291.86 | 111.95B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
106.20 | 183.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.54 | 123.49B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
41.98 | 60.84B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.01 | 53.03B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-08-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-07-28 | Fortgesetzt | UBS | Buy |
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut - Zacks Investment Research
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4? - Zacks Investment Research
Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Zacks Investment Research
Stryker (SYK) Q3 Earnings and Revenues Lag Estimates - Zacks Investment Research
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds? - Zacks Investment Research
Stryker completes ZuriMED acquisition - Medical Buyer
Stryker to participate in the 2026 Jefferies Global Healthcare Conference - Yahoo Finance
14,355 Stryker Corporation $SYK Shares Purchased by Verdence Capital Advisors LLC - MarketBeat
Stryker Corporation $SYK Shares Acquired by Noesis Capital Mangement Corp - MarketBeat
It's Too Soon To Upgrade Stryker Corporation (NYSE:SYK) - Seeking Alpha
Stryker completes acquisition of rotator cuff reinforcement developer ZuriMed - MassDevice
Stryker completes acquisition of rotator cuff tech firm ZuriMED - Investing.com
Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Stryker completes acquisition of ZuriMED to enhance its shoulder offering - GlobeNewswire Inc.
Stryker completes acquisition of ZuriMED to enhance its shoulder offering - GlobeNewswire
Stryker Corporation (SYK) stock price, news, quote and history - Yahoo Finance UK
Stryker (SYK) Stock May Trade At A Discount Despite FDA Clearance - Yahoo Finance
Stryker stock may move 6.3% on Oct. 29 earnings release - Investing.com
Is It Too Late to Buy Stryker Corp (SYK) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
19,374 Stryker Corporation $SYK Shares Acquired by Eagle Rock Investment Company LLC - MarketBeat
Colorado Company donates $30,000 to Stryker Tragedy victims - KSN.com
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Sawyer & Company Inc Purchases New Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Sold by Stillwater Wealth Management Group - MarketBeat
Stryker Corp Stock (SYK) Moved Down by 3.70% on Oct 21: What Investors Need To Know - TradingKey
Stryker stock: BTIG cuts target from USD 358.00 to USD 316.00 - AD HOC NEWS
PAHC or SYK: Which Is the Better Value Stock Right Now? - Zacks Investment Research
2 Dividend Stocks to Buy and Hold Forever - The Motley Fool
Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy - Yahoo Finance
QV Investors Inc. Makes New Investment in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stake Lifted by Nisa Investment Advisors LLC - MarketBeat
A top medical technology stock is trading at a big discount. Here's why I'm buying - CNBC
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Bank Pictet & Cie Europe AG Sells 8,958 Shares of Stryker Corporation $SYK - MarketBeat
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services - The Globe and Mail
ETFs Are Net Sellers of Stryker (SYK) on Friday - Yahoo Finance
Barclays targets Stryker stock at USD 375 after robotics deal - ad-hoc-news.de
Is Stryker Corp. (SYK) Positioned for Above-Market Growth? - Yahoo Finance
Value Partners Investments Inc. Makes New $1 Million Investment in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
2 Industries Beyond AI With Long-Term Demand Drivers for 2027 - Zacks Investment Research
Stryker Corporation $SYK Stock: Talbot Financial LLC Increases Holdings - MarketBeat
Stryker Enters Soft-Tissue Robotics With $400 Million CMR Deal - Zacks Investment Research
Stryker plans $400M investment in CMR Surgical, secures acquisition option - Healthcare IT News
Stryker Corporation $SYK Stock: Generali Investments Management Co LLC Reduces Holdings - MarketBeat
Stryker, Viatris, Flo, Teva, J&J: This Week in Healthcare - Healthcare Digital
Stryker Corporation (SYK) Stock Forecasts - Yahoo Finance
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum? - Zacks Investment Research
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stryker Corp-Aktie (SYK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Aug 19 '26 |
Sale |
340.10 |
50,000 |
17,005,165 |
2,251,375 |
| King Debra | See Remarks |
Aug 18 '26 |
Sale |
336.30 |
826 |
277,787 |
6,210 |
| Debra King | Officer |
Aug 18 '26 |
Proposed Sale |
336.30 |
826 |
277,786 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Proposed Sale |
335.00 |
350,000 |
117,250,000 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Sale |
335.90 |
300,000 |
100,770,963 |
2,301,375 |
| Fletcher Robert S | Officer |
May 28 '26 |
Proposed Sale |
305.59 |
4,544 |
1,388,601 |
0 |
| Fletcher Robert S | VP, Chief Legal Officer |
May 28 '26 |
Sale |
306.87 |
4,544 |
1,394,409 |
10,582 |
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
| STRYKER RONDA E | Director |
May 26 '26 |
Proposed Sale |
313.00 |
310,000 |
97,030,000 |
0 |
| Fink M Kathryn | VP, Chief HR Officer |
May 11 '26 |
Sale |
283.85 |
5,220 |
1,481,671 |
13,137 |
0.59%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):